We use clinical trials to research new diagnosis and treatment approaches for bladder cancer and prostate cancer and to see if they are more effective than the standard approaches already available. This may be testing a new drug, testing a novel surgical technique or giving an existing drug in a different way. We aim to find the approaches that work best and cause the fewest side effects.
New treatment approaches have to go through three main phases of clinical trial to ensure that they are safe and effective. Phase 1 (usually written as “Phase I”) trials are usually small trials, recruiting only a few patients to examine doses and side effects. This early stage work must be completed before we can move on to testing the new treatment to see if it actually works.
By the time a clinical trial has reached Phase III we are aiming to see whether the new treatment is more effective than the best currently available treatment. The difference in success of the new treatment may be very small, so these trials usually involve a lot of patients to ensure that the differences are consistent. Our work frequently involves Phase III trials which we are confident can improve the care we provide.
Our studies look at the effectiveness of new diagnosis and treatment approaches as well as the side effects and impact on your quality of life.